JP2014514299A5 - - Google Patents

Download PDF

Info

Publication number
JP2014514299A5
JP2014514299A5 JP2014503240A JP2014503240A JP2014514299A5 JP 2014514299 A5 JP2014514299 A5 JP 2014514299A5 JP 2014503240 A JP2014503240 A JP 2014503240A JP 2014503240 A JP2014503240 A JP 2014503240A JP 2014514299 A5 JP2014514299 A5 JP 2014514299A5
Authority
JP
Japan
Prior art keywords
methyl
hydroxy
methylsulfonyl
butanamide
pyrazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014503240A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014514299A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2012/051456 external-priority patent/WO2012137099A1/en
Publication of JP2014514299A publication Critical patent/JP2014514299A/ja
Publication of JP2014514299A5 publication Critical patent/JP2014514299A5/ja
Pending legal-status Critical Current

Links

JP2014503240A 2011-04-08 2012-03-27 抗菌剤として有用なイミダゾール、ピラゾールおよびトリアゾール誘導体 Pending JP2014514299A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161473370P 2011-04-08 2011-04-08
US61/473,370 2011-04-08
PCT/IB2012/051456 WO2012137099A1 (en) 2011-04-08 2012-03-27 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents

Publications (2)

Publication Number Publication Date
JP2014514299A JP2014514299A (ja) 2014-06-19
JP2014514299A5 true JP2014514299A5 (enExample) 2014-07-31

Family

ID=45937499

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014503240A Pending JP2014514299A (ja) 2011-04-08 2012-03-27 抗菌剤として有用なイミダゾール、ピラゾールおよびトリアゾール誘導体

Country Status (12)

Country Link
US (1) US8809333B2 (enExample)
EP (1) EP2694481B1 (enExample)
JP (1) JP2014514299A (enExample)
KR (1) KR20130140164A (enExample)
CN (1) CN103492368A (enExample)
AU (1) AU2012238379C1 (enExample)
CA (1) CA2830866A1 (enExample)
IL (1) IL228798A (enExample)
MX (1) MX2013011432A (enExample)
SG (1) SG193458A1 (enExample)
WO (1) WO2012137099A1 (enExample)
ZA (1) ZA201306877B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722686B2 (en) 2008-09-19 2014-05-13 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
CA2899583A1 (en) 2009-12-16 2011-06-23 Pfizer Inc. N-linked hydroxamic acid derivatives useful as antibacterial agents
KR101593288B1 (ko) 2011-03-07 2016-02-11 화이자 인코포레이티드 항균제로서 유용한 플루오로-피리디논 유도체
AU2012238374B2 (en) 2011-04-08 2015-04-02 Pfizer Inc. Isoxazole derivatives useful as antibacterial agents
CN103492368A (zh) 2011-04-08 2014-01-01 辉瑞大药厂 用作抗菌剂的咪唑、吡唑和噻唑衍生物
US9663488B2 (en) * 2013-01-28 2017-05-30 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
AR097617A1 (es) * 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
ES2666130T3 (es) * 2013-12-19 2018-05-03 Idorsia Pharmaceuticals Ltd Derivados antibacterianos de 1H-indazol y 1H-indol
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
KR20170005105A (ko) 2014-05-16 2017-01-11 액테리온 파마슈티칼 리미티드 항균성 퀴나졸린-4(3h)-온 유도체
UA118722C2 (uk) 2014-11-19 2019-02-25 Ідорсія Фармасьютікалз Лтд Антибактеріальні бензотіазольні похідні
ES2756300T3 (es) * 2014-12-16 2020-04-27 Novartis Ag Compuestos de ácido isoxazol hidroxámico como inhibidores de LpxC
AR105646A1 (es) 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
AR105848A1 (es) * 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
AR105889A1 (es) 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
JP2019516723A (ja) * 2016-05-17 2019-06-20 イドーシア ファーマシューティカルズ リミテッドIdorsia Pharmaceuticals Ltd 6−(ブタ−1,3−ジイン−1−イル)ベンゾ[d]チアゾール誘導体
ES2643856B1 (es) * 2016-05-24 2018-08-03 Universidad Del Pais Vasco / Euskal Herriko Unibertsitatea Triazoles para la regulación de la homeostasis de calcio intracelular
AU2017283768B2 (en) 2016-06-14 2019-05-23 Novartis Ag Crystalline form of (R)-4-(5-(cyclopropylethynyl)isoxazol-3-yl)-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide as an antibacterial agent
CN110088087B (zh) * 2016-09-28 2022-08-09 东亚St株式会社 四氢吡啶衍生物及其作为抗菌剂的用途
JP7129420B6 (ja) 2017-03-30 2024-02-02 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト Hpk1阻害剤としてのイソキノリン
US10526343B2 (en) 2018-03-26 2020-01-07 University Of Sharjah Heterocyclic systems and pharmaceutical applications thereof
TW202019905A (zh) 2018-07-24 2020-06-01 瑞士商赫孚孟拉羅股份公司 異喹啉化合物及其用途
TW202024053A (zh) 2018-10-02 2020-07-01 美商建南德克公司 異喹啉化合物及其用途
US11612606B2 (en) 2018-10-03 2023-03-28 Genentech, Inc. 8-aminoisoquinoline compounds and uses thereof
DE202021105689U1 (de) 2021-10-19 2021-11-11 Punit Kumar Dwivedi Intelligentes System zur Verbesserung des Zustands der Batterien von Elektrofahrzeugen durch maschinelles Lernen und künstliche Intelligenz

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59139388A (ja) * 1984-01-20 1984-08-10 Ajinomoto Co Inc トリアゾ−ル−4−カルボン酸誘導体
US4769461A (en) 1986-09-16 1988-09-06 American Home Products Corporation Quinolinyl benzene hydroxamic acids as anti-inflammatory/antiallergic agents
US5110831A (en) 1990-11-30 1992-05-05 Du Pont Merck Pharmaceutical Company Vinylogous hydroxamic acids and derivatives thereof as 5-lipoxygenase inhibitors
EP1052984B1 (en) 1998-02-07 2004-05-12 Vernalis (Oxford) Ltd Antibacterial agents
GB9925470D0 (en) 1999-10-27 1999-12-29 Smithkline Beecham Plc Novel compounds
JPWO2002074298A1 (ja) 2001-03-21 2004-07-08 小野薬品工業株式会社 Il−6産生阻害剤
ES2180456B1 (es) 2001-07-20 2004-05-01 Laboratorios S.A.L.V.A.T., S.A. Isoxazoles sustituidos y su utilizacion como antibioticos.
JP2004196678A (ja) * 2002-12-17 2004-07-15 Dainippon Pharmaceut Co Ltd ピラゾール系誘導体
AU2004204760C1 (en) 2003-01-08 2010-08-19 Novartis Vaccines And Diagnostics, Inc. Antibacterial agents
GB0302431D0 (en) 2003-01-30 2003-03-05 Glaxo Group Ltd Novel compounds
JP2008523098A (ja) 2004-12-10 2008-07-03 エモリー・ユニバーシテイ ウィルス感染および異常細胞増殖の治療用の2′および3′−置換シクロブチルヌクレオシド類縁体
WO2006118155A1 (ja) 2005-04-27 2006-11-09 Ishihara Sangyo Kaisha, Ltd. ビフェニル誘導体又はその塩、並びにそれらを有効成分として含有する農園芸用殺菌剤
WO2006124897A2 (en) 2005-05-13 2006-11-23 Lexicon Genetics Incorporated Methods and compositions for improving cognition
US8088804B2 (en) * 2005-12-15 2012-01-03 Pfizer Inc. N-hydroxyamide derivatives possessing antibacterial activity
WO2008045671A1 (en) 2006-10-06 2008-04-17 Janssen Pharmaceutica, N.V. Matrix metalloprotease inhibitors
US7879911B2 (en) 2007-02-01 2011-02-01 Johnson Alan T Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning
WO2008105515A1 (ja) 2007-02-28 2008-09-04 Taisho Pharmaceutical Co., Ltd. 新規なヒドロキサム酸誘導体
WO2008115262A2 (en) 2007-03-20 2008-09-25 Curis, Inc. Hsp90 inhibitors containing a zinc binding moiety
WO2009069020A1 (en) * 2007-11-27 2009-06-04 Nxp B.V. Contact structure for an electronic circuit substrate and electronic circuit comprising said contact structure
AU2009279949A1 (en) 2008-08-04 2010-02-11 Merck Sharp & Dohme Corp. Urea derivatives as antibacterial agents
WO2010024356A1 (ja) 2008-08-27 2010-03-04 大正製薬株式会社 ナフチリジン-n-オキシドを有する新規ヒドロキサム酸誘導体
US8372885B2 (en) 2008-09-17 2013-02-12 Novartis Ag Organic compounds and their uses
US8722686B2 (en) * 2008-09-19 2014-05-13 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
WO2010100475A1 (en) 2009-03-02 2010-09-10 Astrazeneca Ab Hydroxamic acid derivatives as gram-negative antibacterial agents
EP2488489A2 (en) * 2009-10-13 2012-08-22 Pfizer Inc. C-linked hydroxamic acid derivatives useful as antibacterial agents
CA2899583A1 (en) 2009-12-16 2011-06-23 Pfizer Inc. N-linked hydroxamic acid derivatives useful as antibacterial agents
KR101593288B1 (ko) 2011-03-07 2016-02-11 화이자 인코포레이티드 항균제로서 유용한 플루오로-피리디논 유도체
CN103492368A (zh) 2011-04-08 2014-01-01 辉瑞大药厂 用作抗菌剂的咪唑、吡唑和噻唑衍生物
AU2012238374B2 (en) 2011-04-08 2015-04-02 Pfizer Inc. Isoxazole derivatives useful as antibacterial agents

Similar Documents

Publication Publication Date Title
JP2014514299A5 (enExample)
JP2013514345A5 (enExample)
JP2014518220A5 (enExample)
JP2007530690A5 (enExample)
RU2012116207A (ru) Производные индола в качестве модуляторов crac
AR118840A2 (es) Combinaciones de compuestos activos que comprenden un derivado de (tio)carboxamida y un compuesto fungicida
JP2006518763A5 (enExample)
JP2010505809A5 (enExample)
JP2018535999A5 (enExample)
JP2015533157A5 (enExample)
NZ609955A (en) Sgc stimulators
JP2014523880A5 (enExample)
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
JP2007523181A5 (enExample)
JP2019524705A5 (enExample)
IL303196A (en) Heteroaryl-substituted pyridines and methods of use
JP2015526408A5 (enExample)
RU2009111113A (ru) Мидуляторы mglur5
RU2015106784A (ru) Частично насыщенное азотсодержащее гетероциклическое соединение
HRP20160172T1 (hr) Spojevi koji su inhibitori metaloenzima
CA2462289A1 (en) Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
JP2014518219A5 (enExample)
HRP20170019T1 (hr) Novi pirol-inhibitori od reduktaze s-nitrozoglutationa kao terapeutska sredstva
JP2005511543A5 (enExample)
JP2014507464A5 (enExample)